Sort   by:  
 Page size 
TranscriptomicsDivergent genome expression profiles during hepatic ischemia in young and adult mice
Experimental Design: 1. The goal of the experiment: Age-Related Genome Expression Profiles During Hepatic Ischemia 2. Brief description of the experiment: Hepatic ischemia/reperfusion (I/R) injury is a complication of liver surgery, transplantation and shock and differs with age. In the present stu...
ORGANISM(S): Mus musculus 
2010-05-26 | E-GEOD-10652 | biostudies-arrayexpress
TranscriptomicsAge-dependent gene expression profiles after hepatic ischemia/reperfusion in mice
Experimental Design: 1. The goal of the experiment: Age-Dependent Gene Expression Profiles After Hepatic Ischemia/Reperfusion: Implications for the AP-1 and Ubiquitin-Proteosome Pathways 2. Brief description of the experiment: Hepatic ischemia/reperfusion (I/R) injury is a complication of liver surg...
ORGANISM(S): Mus musculus 
2010-05-26 | E-GEOD-10654 | biostudies-arrayexpress
TranscriptomicsActivation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective. doi: 10.1038/nm.4109
The multiple claims about reactivation of the embryonic stem cell (ESC) pluripotency factor OCT4 in somatic cells are highly controversial due to the fact that there is no direct evidence that OCT4 has a functional role in cells other than ESCs. Herein we demonstrate that smooth muscle cell (SMC)-sp...
ORGANISM(S): Mus musculus 
2016-05-15 | E-GEOD-75044 | biostudies-arrayexpress
TranscriptomicsLymph node CD4+ T cell and thioglycollate-elicited peritoneal macrophage expression data from naM-CM-/ve young and old SJL/J and SJL-ChrY^B10.S male mice
Understanding the DNA elements that constitute and control the regulatory genome is critical for the appropriate therapeutic management of complex diseases. Here, using chromosome Y (ChrY) consomic mouse strains on the C57BL/6J background, we show that susceptibility to two diverse animal models of ...
ORGANISM(S): Mus musculus 
2013-05-28 | E-GEOD-47437 | biostudies-arrayexpress
UnknownImpact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
Not available
S-EPMC10033295 | biostudies-literature
UnknownAssessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
Not available
S-EPMC8728628 | biostudies-literature
UnknownRivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
Not available
S-EPMC6662613 | biostudies-literature
UnknownAmikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Not available
S-EPMC9078215 | biostudies-literature
UnknownSystemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Not available
S-EPMC10436185 | biostudies-literature
UnknownInterplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Not available
S-EPMC9634600 | biostudies-literature
Sort   by:  
 Page size